EpiPen shortage officially over: TGA

Supply issues with the device have finally been resolved after a nine-month national shortage
Geir O'Rourke

Australia’s EpiPen shortage is officially over, nearly nine months after manufacturing problems saw the devices disappear from pharmacy shelves.

The TGA says it has received confirmation that supply issues affecting EpiPen 300µg adrenaline have now been sufficiently resolved and there are now enough of the auto-injectors in pharmacies to meet demand from patients.